首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

2077235

血管栓塞治療市場：栓塞治療方法、應用、區域規模、佔有率、前景和機會分析（2025-2032 年）

Vascular Embolization Market, By Embolization Technique, By Application, By Geography Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，血管栓塞治療市場規模將達到 21.284 億美元，到 2033 年將達到 41.214 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 9.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	21.284億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.90%	2033年市場規模預測：	41.214億美元

血管栓塞術是指栓子隨血液循環進入血管並滯留在血管內的過程。這是一種微創治療方法，可以阻塞一條或多條血管或異常血管通路。血管栓塞劑透過機械阻塞的方式，立即阻斷血管或血管區域的血流。這些栓塞劑經由導管釋放到血液中，以生物或機械方式阻塞目標血管。阻塞可以是永久性的，也可以是暫時性的。血管栓塞術具有成功率高、很少需要麻醉劑、恢復時間短、感染風險極低且不留疤痕等優點。栓塞術是介入放射學中常見且有效的治療方法，為開放性手術提供了一種替代方案。

市場動態：

預計在預測期內，臨床試驗數量的增加以及研發投入的活性化將推動全球血管栓塞市場的成長。例如，2021年3月，Instylla公司宣布，其用於治療高血管腫瘤的Embrace水凝膠栓塞系統（HES）已開始招募首批患者參與一項大型全球隨機臨床試驗。

2022年3月，Instylla公司宣布，其用於治療高血管腫瘤的Embrace水凝膠栓塞系統（HES）的首個人體臨床試驗結果已發表於《血管與介入放射學雜誌》（JVIR）。研究表明，HES能夠有效栓塞所有8名接受治療的患者的惡性及良性高血管腫瘤，阻斷腫瘤血流，並透過30天的影像學隨訪證實，實現了技術上的成功和栓塞的持續性。

本研究的主要特點：

本研究確定了各個細分市場的潛在商機，並為該市場說明了一個有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數，介紹了全球血管栓塞市場主要參與者的概況。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球血管栓塞市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用全球血管栓塞市場分析中使用的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 2,128.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.90%	2033 Value Projection:	USD 4,121.4 Mn

Vascular embolization refers to the passage and lodging of an embolus within the bloodstream. It is a minimally invasive treatment that blocks one or more blood vessels or abnormal vascular channels. Vascular embolization agents are used to acutely stop flow in blood vessel or vascular area by the means of mechanical occlusion. These agents are released into the blood through a catheter to biologically or mechanically occlude the target vessel; permanently or temporarily. High success rate, rare use of anesthetics, faster recovery time, minimal risk of infection, and no scarring are some features of vascular embolization agents. Embolization is a common and effective procedure in interventional radiology. It is an alternative to open surgery.

Market Dynamics:

Increasing number of clinical trials and increase in research and development is expected to augment the growth of the global vascular embolization market during the forecast period. For instance, in March 2021, Instylla Inc. reported the enrollment of the first patients in the pivotal Embrace Hydrogel Embolic System (HES) global randomized clinical trial for the treatment of hypervascular tumors.

In March 2022, Instylla announced the publication of results from the first-in-human clinical trial of Embrace Hydrogel Embolic System (HES) for the treatment of hypervascular tumors, in the Journal of Vascular and Interventional Radiology (JVIR). The study demonstrated that HES effectively embolized malignant & benign hypervascular tumors by blocking tumor blood supply with technical success and persistent embolization, as noted in imaging follow-up at 30-days, in all eight patients treated on this study.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global vascular embolization market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Shape Memory Medical Inc., Terumo Corp, Abbott Laboratories, Stryker Corporation, Cook Medical, Medtronic PLC, Merit Medical Systems Inc., Penumbra Inc., Johnson and Johnson (Cerenovus), and Boston Scientific Corporation, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global vascular embolization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular embolization market.

Detailed Segmentation:

Global Vascular Embolization Market, By Embolization Technique (Revenue, USD Mn, 2021 - 2033)
Coiling Devices
Non-coiling Devices
Global Vascular Embolization Market, By Application (Revenue, USD Mn, 2021 - 2033)
Peripheral Vascular Disease
Oncology
Neurology
Urology
Other Applications
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa

Market Dynamics
- Increasing prevalence of vascular diseases
- Complications associated with embolization procedures
- Increasing demand for vascular embolization devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Vascular Embolization Market, By Embolization Technique, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Coiling Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Non-coiling Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Global Vascular Embolization Market, By Application, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Peripheral Vascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Urology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global Vascular Embolization Market, By Region, 2021-2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)

7. Competitive Landscape

Shape Memory Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Penumbra Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stryker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cook Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merit Medical Systems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson and Johnson (Cerenovus)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

8. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

9. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

血管栓塞治療市場－2026-2032年全球市場預測

2025年全球栓塞市場報告

血管栓塞裝置的全球市場

FAQ

血管栓塞治療市場：栓塞治療方法、應用、區域規模、佔有率、前景和機會分析（2025-2032 年）